Total Assets Summary of Kunming Longjin Pharmaceutical Co., Ltd.

Kunming Longjin Pharmaceutical Co., Ltd.'s latest annual total assets in 2023 was 631.63 Million CNY , down -15.47% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd.'s latest quarterly total assets in 2024 Q3 was 597.37 Million CNY , down -2.67% from previous quarter.
Kunming Longjin Pharmaceutical Co., Ltd. reported annual total assets of 747.2 Million CNY in 2022, down -9.68% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd. reported annual total assets of 827.27 Million CNY in 2021, down -1.72% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd. reported quarterly total assets of 613.73 Million CNY for 2024 Q2, down -4.3% from previous quarter.
Kunming Longjin Pharmaceutical Co., Ltd. reported quarterly total assets of 641.27 Million CNY for 2024 Q1, up 1.53% from previous quarter.

Annual Total Assets Chart of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Total Assets of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Total Assets	Total Assets Growth
2023	631.63 Million CNY	-15.47%
2022	747.2 Million CNY	-9.68%
2021	827.27 Million CNY	-1.72%
2020	841.75 Million CNY	4.32%
2019	806.89 Million CNY	2.46%
2018	787.54 Million CNY	0.3%
2017	785.22 Million CNY	3.36%
2016	759.67 Million CNY	8.7%
2015	698.85 Million CNY	60.44%
2014	435.58 Million CNY	-1.58%
2013	442.56 Million CNY	20.24%
2012	368.05 Million CNY	28.08%
2011	287.36 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q3	597.37 Million CNY	-2.67%
2024 Q2	613.73 Million CNY	-4.3%
2024 Q1	641.27 Million CNY	1.53%
2023 Q1	685.87 Million CNY	-8.21%
2023 Q4	631.63 Million CNY	-7.53%
2023 FY	631.63 Million CNY	-15.47%
2023 Q3	683.05 Million CNY	-1.83%
2023 Q2	695.78 Million CNY	1.45%
2022 Q4	747.2 Million CNY	-6.95%
2022 Q3	803.01 Million CNY	-0.27%
2022 Q2	805.16 Million CNY	-1.48%
2022 Q1	817.23 Million CNY	-1.21%
2022 FY	747.2 Million CNY	-9.68%
2021 Q1	993.72 Million CNY	18.05%
2021 Q2	1.03 Billion CNY	3.74%
2021 Q3	1.04 Billion CNY	1.43%
2021 Q4	827.27 Million CNY	-20.88%
2021 FY	827.27 Million CNY	-1.72%
2020 Q1	800.5 Million CNY	-0.79%
2020 Q2	794.91 Million CNY	-0.7%
2020 FY	841.75 Million CNY	4.32%
2020 Q4	841.75 Million CNY	2.01%
2020 Q3	825.18 Million CNY	3.81%
2019 Q4	806.89 Million CNY	-2.03%
2019 FY	806.89 Million CNY	2.46%
2019 Q3	823.58 Million CNY	6.27%
2019 Q2	774.98 Million CNY	0.58%
2019 Q1	770.54 Million CNY	-2.16%
2018 Q4	787.54 Million CNY	2.55%
2018 Q2	771.03 Million CNY	-3.43%
2018 Q3	767.95 Million CNY	-0.4%
2018 FY	787.54 Million CNY	0.3%
2018 Q1	798.41 Million CNY	1.68%
2017 Q2	742.6 Million CNY	-3.84%
2017 FY	785.22 Million CNY	3.36%
2017 Q4	785.22 Million CNY	1.31%
2017 Q3	775.11 Million CNY	4.38%
2017 Q1	772.28 Million CNY	1.66%
2016 Q2	712.13 Million CNY	-1.55%
2016 FY	759.67 Million CNY	8.7%
2016 Q4	759.67 Million CNY	5.8%
2016 Q3	718 Million CNY	0.82%
2016 Q1	723.31 Million CNY	3.5%
2015 Q1	712.73 Million CNY	63.63%
2015 Q4	698.85 Million CNY	4.63%
2015 Q2	667.24 Million CNY	-6.38%
2015 Q3	667.92 Million CNY	0.1%
2015 FY	698.85 Million CNY	60.44%
2014 FY	435.58 Million CNY	-1.58%
2014 Q1	- CNY	0.0%
2014 Q2	407.39 Million CNY	0.0%
2014 Q3	420.24 Million CNY	3.15%
2014 Q4	435.58 Million CNY	3.65%
2013 FY	442.56 Million CNY	20.24%
2012 FY	368.05 Million CNY	28.08%
2011 FY	287.36 Million CNY	0.0%

Peer Total Assets Comparison of Kunming Longjin Pharmaceutical Co., Ltd.

Name	Total Assets	Total Assets Difference
Jilin Aodong Pharmaceutical Group Co., Ltd.	32.26 Billion CNY	98.042%
Jinling Pharmaceutical Company Limited	4.55 Billion CNY	86.12%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	7.52 Billion CNY	91.601%
LanZhou Foci Pharmaceutical Co.,Ltd.	2.52 Billion CNY	75.015%
Zhuhai Rundu Pharmaceutical Co., Ltd.	2.22 Billion CNY	71.647%
PharmaBlock Sciences (Nanjing), Inc.	5.1 Billion CNY	87.625%
Jiuzhitang Co., Ltd.	5.32 Billion CNY	88.149%
Shenzhen Neptunus Bioengineering Co., Ltd.	32.3 Billion CNY	98.045%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.39 Billion CNY	85.616%
Dong-E-E-Jiao Co.,Ltd.	13.3 Billion CNY	95.253%
Livzon Pharmaceutical Group Inc.	25.04 Billion CNY	97.478%
Hainan Haiyao Co., Ltd.	7.36 Billion CNY	91.426%
Tus-Pharmaceutical Group Co., Ltd.	1.15 Billion CNY	45.129%
Renhe Pharmacy Co., Ltd.	7.44 Billion CNY	91.516%
Changchun High-Tech Industries (Group) Inc.	30.74 Billion CNY	97.945%
PKU HealthCare Corp.,Ltd.	2.43 Billion CNY	74.095%
Chengdu Huasun Technology Group Inc., Ltd.	2.13 Billion CNY	70.394%
Shandong Shanda Wit Science and Technology Co., Ltd.	5.19 Billion CNY	87.849%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	40.14 Billion CNY	98.427%
Zhejiang NHU Company Ltd.	39.15 Billion CNY	98.387%
Huapont Life Sciences Co., Ltd.	30.72 Billion CNY	97.944%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	7.98 Billion CNY	92.091%
Shandong Wohua Pharmaceutical Co., Ltd.	1.14 Billion CNY	44.821%
Hengkang Medical Group Co., Ltd.	6.08 Billion CNY	89.612%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	6.45 Billion CNY	90.22%
Qianjiang Yongan Pharmaceutical Co., Ltd.	2.34 Billion CNY	73.089%
Zhejiang Yatai Pharmaceutical Co., Ltd.	1.42 Billion CNY	55.81%
Hunan Hansen Pharmaceutical Co., Ltd.	2.33 Billion CNY	72.967%
Harbin Medisan Pharmaceutical Co., Ltd.	3.44 Billion CNY	81.654%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	3.01 Billion CNY	79.085%
Pacific Shuanglin Bio-pharmacy Co., LTD	8.63 Billion CNY	92.681%
Beijing Beilu Pharmaceutical Co., Ltd	2.81 Billion CNY	77.597%
Huaren Pharmaceutical Co., Ltd.	5.16 Billion CNY	87.773%
Tianjin Ringpu Bio-Technology Co.,Ltd.	6.59 Billion CNY	90.424%
Walvax Biotechnology Co., Ltd.	15.58 Billion CNY	95.948%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	930.4 Million CNY	32.112%
Nanjing Hicin Pharmaceutical Co., Ltd.	1.41 Billion CNY	55.484%
Hainan Poly Pharm. Co., Ltd	6.28 Billion CNY	89.953%
Jiangxi Synergy Pharmaceutical Co., Ltd.	3.22 Billion CNY	80.393%
Wuhan Hiteck Biological Pharma Co.,Ltd	2.97 Billion CNY	78.742%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	6.33 Billion CNY	90.034%
Tibet AIM Pharm. Inc.	927.74 Million CNY	31.917%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	1.43 Billion CNY	55.925%
Changjiang Pharmaceutical Group Co., Ltd.	3.44 Billion CNY	81.669%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	1.54 Billion CNY	59.057%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.33 Billion CNY	52.745%
Guangdong Lifestrong Pharmacy Co., Ltd.	855.53 Million CNY	26.171%
Honz Pharmaceutical Co., Ltd.	2.16 Billion CNY	70.834%
Baotou Dongbao Bio-Tech Co.,Ltd	2.74 Billion CNY	76.965%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	5.26 Billion CNY	87.993%
Apeloa Pharmaceutical Co.,Ltd	12.76 Billion CNY	95.053%
Beijing SL Pharmaceutical Co., Ltd.	6.27 Billion CNY	89.939%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	19.2 Billion CNY	96.711%
Xiamen Kingdomway Group Company	5.35 Billion CNY	88.201%
Yunnan Baiyao Group Co.,Ltd	53.78 Billion CNY	98.826%
Northeast Pharmaceutical Group Co., Ltd.	15.27 Billion CNY	95.865%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	11.83 Billion CNY	94.663%
Hybio Pharmaceutical Co., Ltd.	3.27 Billion CNY	80.726%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	8.52 Billion CNY	92.595%
Anhui Huangshan Capsule Co., Ltd.	1.1 Billion CNY	42.739%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	2.12 Billion CNY	70.276%
Hunan Er-Kang Pharmaceutical Co., Ltd	5.47 Billion CNY	88.472%
Fuan Pharmaceutical (Group) Co., Ltd.	5.97 Billion CNY	89.43%
Fujian Cosunter Pharmaceutical Co., Ltd.	1.61 Billion CNY	60.877%
Shenzhen Kangtai Biological Products Co., Ltd.	15.08 Billion CNY	95.813%
Dezhan Healthcare Company Limited	5.37 Billion CNY	88.257%
Shanxi Zhendong Pharmaceutical Co.,Ltd	6.18 Billion CNY	89.78%
Jinghua Pharmaceutical Group Co., Ltd.	3.18 Billion CNY	80.169%
Sunflower Pharmaceutical Group Co.,Ltd	6.88 Billion CNY	90.822%
Harbin Gloria Pharmaceuticals Co., Ltd	3.15 Billion CNY	79.964%
Changzhou Qianhong Biopharma CO.,LTD	2.76 Billion CNY	77.165%
ApicHope Pharmaceutical Co., Ltd	4.4 Billion CNY	85.662%
Shenzhen Weiguang Biological Products Co., Ltd.	2.87 Billion CNY	78.044%
Betta Pharmaceuticals Co., Ltd.	9.14 Billion CNY	93.095%
Huadong Medicine Co., Ltd	33.5 Billion CNY	98.115%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	4.52 Billion CNY	86.027%
Guizhou Xinbang Pharmaceutical Co., Ltd.	9.24 Billion CNY	93.168%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	5.78 Billion CNY	89.073%
Beijing Aosaikang Pharmaceutical Co., Ltd.	3.52 Billion CNY	82.076%
Shanghai Kaibao Pharmaceutical CO.,Ltd	4.57 Billion CNY	86.208%
Shandong Xinhua Pharmaceutical Company Limited	8.35 Billion CNY	92.439%
Jiangsu Nhwa Pharmaceutical Co., LTD	7.32 Billion CNY	91.381%
Beijing Science Sun Pharmaceutical Co., Ltd.	3.62 Billion CNY	82.562%
Teyi Pharmaceutical Group Co.,Ltd	2.51 Billion CNY	74.862%
Jinhe Biotechnology CO., LTD.	5.45 Billion CNY	88.418%
Chongqing Pharscin Pharmaceutical Co., Ltd.	1.85 Billion CNY	65.884%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	6.99 Billion CNY	90.967%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	5.11 Billion CNY	87.657%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	7.34 Billion CNY	91.405%

Global Stocks Search

Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ)

Total Assets Summary of Kunming Longjin Pharmaceutical Co., Ltd.

Annual Total Assets Chart of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Total Assets of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Total Assets Comparison of Kunming Longjin Pharmaceutical Co., Ltd.